Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 18, 2001

View Archived Issues

Oxigene reports update on vascular targeting program

ICN granted orphan drug status for Tiazole

PhotoCure seeks E.U. approval of Metvix for second indication

ArQule and Nanodesign establish drug design technology alliance

New tumor-specific cancer vaccines developed at BioPulse head for clinical trials

Updated status of merger of IGT and NTB

Paratek and GlaxoSmithKline reach milestone in antibacterial alliance

Schering-Plough's Aerius/NeoClarityn approved in E.U. for treatment of seasonal allergic rhinitis

Versicor and Novartis reach third milestone in antiinfective alliance

La Jolla reports that 90% of lupus patients have key antibodies

U.K. research group designs novel DNA minor groove-binding head-to-head bisbenzimidazole

Genzyme Molecular Oncology and MGH collaborate on HIV vaccine

In vivo evidence supporting bone marrow as a source of neural cells

Unimed now sole marketer of Marinol

Boston Life Sciences reports discovery of protein production method

King and Novavax join forces in the area of women's healthcare products

Structurally novel series of 5-ht6 receptor antagonists evaluated for SAR

Controversy over inhaled corticosteroid use in COPD laid to rest by NHLBI study

Development of Fibrostat accelerated in Canada

Biokeys obtains exclusive worldwide license to and furthers development of Thiovir

Tacrolimus claimed for conditions associated with cartilage damage

Chemokine inhibitors described by Teijin in recent patent

Adenosine A1 receptor agonist prodrugs for oral administration

Novel agents for epilepsy and other CNS disorders a focus of investigation at Pfizer

New PDE4/TNF production inhibitors disclosed by Korean lab

Mutilin derivatives and their use in antiinfective therapy

Novel tubulin polymerization inhibitors from Abbott inhibit cancer cell proliferation

Japanese patent covers new antitumor compounds designed by Kyowa Hakko

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.